Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR and GR blockade effects on fear memory reconsolidation and extinction
2010-023849-30Phase 4Active
- Sponsor
- University of Amsterdam
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of spironolactone and mifepristone (2 arms), sponsored by University of Amsterdam. Primary endpoint: Acoustic fear-potentiated startle response. Started Dec 2010; status: active.
02
Drugs
spironolactonemifepristone
Beyond the preview
Go deeper on 2010-023849-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023849-30.